SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GZMO
An SI Board Since November 1998
Posts SubjectMarks Bans Symbol
438 23 0 GZMO
Emcee:  mike mulhearn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
263 Genzyme Molecular Oncology Investigators See Immune Response in Melanoma Cancersim1-5/22/2000
262 *OT* I don't have any shareprice targets anymore for any of the biotechs I Mike McFarland-5/16/2000
261 Do you still have a target of $100 on this stock, or does that date back to thejeffbas-5/16/2000
260 Only $25? All we need is a good ASCO showing and its there. I like Mike's tRWReeves-5/16/2000
259 SG Cowen upgrade to strong buy with a price target of $25. D.Lu-5/16/2000
258 Probably wanted to offer you a job in IR. BIG pop on the open for Giz. RWRRWReeves-5/16/2000
257 I think it was about voting your proxy.jeffbas-5/16/2000
256 All aboard! Say, I got a call from Genzyme the other day--they didn't botheMike McFarland-5/16/2000
255 Final pre-ASCO call. RWRRWReeves-5/16/2000
254 I listened in as well, a handful of the fusion trials coming, plus one vaccine Mike McFarland-4/19/2000
253 According to one analyst in today's conference call, the draw from the GenzD.Lu-4/19/2000
252 In the FWIW category: aacr00.agora.com "A COMPREHENSIVE APPROACH TO HIGHPseudo Biologist-4/6/2000
251 With the buyback option in place there's only so far GZMO can remove itselfrkrw-3/23/2000
250 Precisely. This offering is designed to do just that AND to give the company sejeffbas-3/23/2000
249 Genzyme Molecular Oncology Announces Public Offering of 3,000,000 Shares of CoMike McFarland-3/23/2000
248 <i>Genzyme holds a buyback option on GZMO. </i> As rkrw correctly Biomaven-3/9/2000
247 Genzyme holds a buyback option on GZMO. Calling GZMO separate from GENZ is falrkrw-3/9/2000
246 GENZ does not benefit from any developments relating to GZMO. They are separatejeffbas-3/9/2000
245 How come GENZ has not moved on the news in after hours ??? I would think it wouHG-3/9/2000
244 Nice piece of news. GZMO locks up exclusive rights to dendritic/cancer cell fusLarry Liebman-3/8/2000
243 This may be the correct trial: clinicaltrials.gov No, cancel that--try this quMike McFarland-2/29/2000
242 Here's some publicity from the Boston Globe: boston.com (Link doesn'tBiomaven-2/29/2000
241 Jeff,....you have to know the biological behavior of hypernephromas(renal cell puborectalis-2/29/2000
240 In my opinion, Yahoo GZMO thread posts 1086-1088 are must reading. Even though jeffbas-2/29/2000
239 thanks, PB...... chicagotribune.comscaram(o)uche-2/28/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News